Vimarsana
Biggest News Aggregation in the World

Page 3 - Imux News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Imux. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Imux Today - Breaking & Trending Today

Immunic, Inc. (NASDAQ:IMUX) Short Interest Up 6.9% in June - Vimarsana News

Immunic, Inc. (NASDAQ:IMUX) Short Interest Up 6.9% in June

Immunic, Inc. (NASDAQ:IMUX – Get Free Report) was the target of a large growth in short interest in the month of June. As of June 30th, there was short interest totalling 2,170,000 shares, a growth of 6.9% from the June 15th total of 2,030,000 shares. Based on an average daily volume of 1,040,000 shares, the […]

Source: wkrb13.com
These 2 'Strong Buy' Penny Stocks Could Soar to $25 (Or Higher), Says Piper Sandler - Vimarsana News

These 2 'Strong Buy' Penny Stocks Could Soar to $25 (Or Higher), Says Piper Sandler

Whether you love them or hate them, penny stocks are contentious. These tickers, which trade for less than $5 per share, have earned a reputation on Wall Street for their divisive nature, leaving investors struggling to find common ground on the matter. The appeal is clear. For the same price as one share of a more well-known company, investors can snap up hundreds of shares of a penny stock. What’s more, the fact that even minor share price appreciation can translate to irresistible percentage

Source: yahoo.com
Vivo Capital LLC Purchases Shares of 632,184 Immunic, Inc. (NASDAQ:IMUX) - Vimarsana News

Vivo Capital LLC Purchases Shares of 632,184 Immunic, Inc. (NASDAQ:IMUX)

Vivo Capital LLC acquired a new stake in shares of Immunic, Inc. (NASDAQ:IMUX – Get Rating) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 632,184 shares of the company’s stock, valued at approximately $833,000. Vivo Capital LLC owned approximately […]

Immunic (NASDAQ:IMUX) Coverage Initiated at StockNews.com - Vimarsana News

Immunic (NASDAQ:IMUX) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Immunic (NASDAQ:IMUX – Get Rating) in a research report sent to investors on Thursday morning. The firm issued a sell rating on the stock. Separately, Wedbush reiterated an outperform rating and issued a $5.00 price objective on shares of Immunic in a report on Tuesday, January 31st. One investment […]

StockNews.com Begins Coverage on Immunic (NASDAQ:IMUX) - Vimarsana News

StockNews.com Begins Coverage on Immunic (NASDAQ:IMUX)

StockNews.com started coverage on shares of Immunic (NASDAQ:IMUX – Get Rating) in a research report report published on Thursday morning. The firm issued a sell rating on the stock. Separately, Wedbush restated an outperform rating and set a $5.00 target price on shares of Immunic in a report on Tuesday, January 31st. One investment analyst […]